EMYRIA LIMITED (EMD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EMD - EMYRIA LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: N/A
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.059

27 Mar
2024

0.000

OPEN

$0.06

0.000

HIGH

$0.06

17,130

LOW

$0.06

FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 20192020202120222023
EPS Basic xxxxxxxxxxxx-1.8
DPS All xxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxx1.6 M
Book Value Per Share xxxxxxxxxxxx2.2
Net Operating Cash Flow xxxxxxxxxxxx-3.8 M
Net Profit Margin xxxxxxxxxxxx-322.21 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20192020202120222023
Return on Capital Employed xxxxxxxxxxxx-78.25 %
Return on Invested Capital xxxxxxxxxxxx-75.35 %
Return on Assets xxxxxxxxxxxx-55.74 %
Return on Equity xxxxxxxxxxxx-78.25 %
Return on Total Capital xxxxxxxxxxxx-94.78 %
Free Cash Flow ex dividends xxxxxxxxxxxx-3.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20192020202120222023
Short-Term Debt xxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxx0 M
Total Debt xxxxxxxxxxxx1 M
Goodwill - Gross xxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxx3 M
Price To Book Value xxxxxxxxxxxx5.67

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20192020202120222023
Capex xxxxxxxxxxxx3.2 M
Capex % of Sales xxxxxxxxxxxx203.06 %
Cost of Goods Sold xxxxxxxxxxxx5 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxx4 M
Research & Development xxxxxxxxxxxx2 M
Investments - Total xxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

EMD STOCK CHART